The EBB project can support Competent National Authorities (CNAs) to achieve a smooth implementation at the national level of the EU Regulation 511/2014 on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization (ABS regulation).

The EBB consortium will carry out use-cases involving end-users of MBRs for commercial research (typically biotech SMEs), providers (biobanks) and Competent National Authorities (CNAs), in order to understand the practicalities of Marine Biological Resources acquisition / provision in compliance with ABS regulations and develop a set of Best Practice Guidelines. By bringing together end-users, providers and CNAs the EBB promote consensual national implementation of ABS regulations and contribute to fulfilling the main objective of the Nagoya Protocol.

- End-users practical use-cases: understanding the practical implications for end-users of the application of procedures to comply with ABS regulations when accessing MBRs

- Best Practice Guidelines on Accessing MBRs for Commercial or close-to-market Research under ABS legislation

EBB, the European Blue Biobank.